9/9/21–Saint Simons Island, GA: Intelivation Technologies, a medical device company with a growing product portfolio announced today that they have achieved FDA 510(k) Clearance of the Advantage-C™ PEEK Cervical Interbody Fusion device.
The Advantage-C™ Device is designed to be used in skeletally mature patients in levels C2-T1 in conjunction with fixation for ACDF (anterior cervical discectomy and fusion) procedures. Advantage-C™ was developed to optimize fusion, while maintaining elasticity that is similar to bone and radiolucency of the cage body. President Amit Sinha stated, “I am excited about the FDA Approval of Advantage-C™ and the myriad of efficiencies this device will bring to both surgeons and hospital systems alike.” CEO Rob Anderson added “Our growing line of interbody devices further drives home our commitment to innovating cost-effective spinal solutions that consistently provide superior clinical results, and the Management Team looks forward to a successful launch during the 36th Annual NASS Meeting in Boston September 29-Ocotber 2, 2021.”
9/1/21–Saint Simons Island, GA: Intelivation Technologies, a medical device company with a cutting-edge spinal implant product portfolio announced today that they have achieved FDA 510(k) Clearance of the Golden Isles Pedicle Screw System™.
The Golden Isles Pedicle Screw System™ is designed to provide immobilization and stabilization of spinal segments in skeletally mature patients in treating the lumbar and sacral spine. The system is intended for posterior, non-cervical pedicle fixation in
skeletally mature patients for treating degenerative disc disease, spondylolisthesis, trauma, deformities as well as pseudoarthrosis and failed previous fusions.
President Amit Sinha remarked, “The modularity of the Golden Isles Pedicle Screw System™ enables the surgeon greater versatility, efficiency, and visibility to achieve superior patient outcomes for the most difficult degenerative and traumatic procedures.” CEO Rob Anderson added, “The simplicity of the system along with the strength of the tulip and screw interface is unsurpassed compared to other options that are currently available on the market.”
Golden Isles showcases both standard and reduction tulips along with a comprehensive set of insertion and reduction instruments. The Management Team looks forward to a successful launch during the 36th Annual NASS Meeting in Boston September 29-Ocotber 2, 2021.
6/21/21–Saint Simons Island, GA: Intelivation Technologies, a medical device company with a cutting edge lower extremity portfolio announced today that they are launching the TruTrackTM Memory Staple System. The TruTrackTM system will be on display at the firm’s technology suite during the Footprints In The Sand Podiatry Institute Conference being held in Hilton Head Island, SC June 24-27 2021. “The TruTrackTM represents a breakthrough in memory staple fixation instrumentation and furthers our mission to bring products to market that result in positive change for patients’ lives,” said Amit Sinha, President of Intelivation Technologies. Mr. Sinha also added, “I am thrilled with how fast our talented team brought this unique offering to market. We are looking forward to rapidly adding to our product portfolio through the remainder of 2021 and beyond.”
The TruTrackTM features novel instrumentation designed for more reliable and consistent insertion techniques during a wide variety of intraoperative conditions. Dr. David Murphy commented on the TruTrackTM Staple, “The TruTackTM Staple System provides a highly dependable and more efficient approach for surgeons. Compared to traditional methods that can be plagued with drill hole obscuration, the TruTrackTM System lends itself towards less soft tissue disruption, resulting in improved surgical outcomes for patients. The implant itself is very low profile and can be applicable to a wide variety of degenerative conditions and deformities of the foot.”
Intelivation Technologies, headquartered in Saint Simons Island, GA and dedicated to research and development, is focused on bringing game-changing products to market that make patients’ lives better. For further inquiries, interested parties may email firstname.lastname@example.org.